Composite intestinal adenoma-microcarcinoid(CIAM)is a rare intestinal lesion consisting of conventional adenoma and small,well differentiated carcinoid[microcarcinoid(MC)]at its base.The incidence of CIAM is 3.8%in su...Composite intestinal adenoma-microcarcinoid(CIAM)is a rare intestinal lesion consisting of conventional adenoma and small,well differentiated carcinoid[microcarcinoid(MC)]at its base.The incidence of CIAM is 3.8%in surgically resected colorectal polyps.While its pathogenesis is unknown,studies support the role of Wnt/β-catenin pathway in the tumorigenesis of CIAM.CIAMs have been primarily reported in the colon wherein they present as polyps with well-defined margins,similar to conventional adenomatous polyps.MC is usually found in adenomatous polyps with high-risk features such as large size,villous architecture,or high grade dysplasia.Histologically,the MC component is often multifocal and spans 3.9 to 5.8 millimeters in size.MC is usually confined within the mucosa but occasional CIAM cases with MC extending to the submucosa have been reported.MC of CIAM demonstrates bland cytology and inconspicuous proliferative activity.The lesional cells are positive for synaptophysin and 60%to 100%of cases show nuclearβ-catenin positivity.MC poses a diagnostic challenge with its morphologic and immunohistochemical resemblance to both benign and malignant lesions,including squamous morules/metaplasia,adenocarcinoma,squamous cell carcinoma,sporadic neuroendocrine tumor and goblet cell adenocarcinoma.CIAM is an indolent lesion with a favorable outcome.Complete removal by polypectomy is considered curative.Awareness and recognition of this rare entity will help arrive at correct diagnosis and improve patient care.Currently,CIAM is not recognized as a subtype of mixed neuroendocrine-nonneuroendocrine neoplasm by WHO.展开更多
文摘Composite intestinal adenoma-microcarcinoid(CIAM)is a rare intestinal lesion consisting of conventional adenoma and small,well differentiated carcinoid[microcarcinoid(MC)]at its base.The incidence of CIAM is 3.8%in surgically resected colorectal polyps.While its pathogenesis is unknown,studies support the role of Wnt/β-catenin pathway in the tumorigenesis of CIAM.CIAMs have been primarily reported in the colon wherein they present as polyps with well-defined margins,similar to conventional adenomatous polyps.MC is usually found in adenomatous polyps with high-risk features such as large size,villous architecture,or high grade dysplasia.Histologically,the MC component is often multifocal and spans 3.9 to 5.8 millimeters in size.MC is usually confined within the mucosa but occasional CIAM cases with MC extending to the submucosa have been reported.MC of CIAM demonstrates bland cytology and inconspicuous proliferative activity.The lesional cells are positive for synaptophysin and 60%to 100%of cases show nuclearβ-catenin positivity.MC poses a diagnostic challenge with its morphologic and immunohistochemical resemblance to both benign and malignant lesions,including squamous morules/metaplasia,adenocarcinoma,squamous cell carcinoma,sporadic neuroendocrine tumor and goblet cell adenocarcinoma.CIAM is an indolent lesion with a favorable outcome.Complete removal by polypectomy is considered curative.Awareness and recognition of this rare entity will help arrive at correct diagnosis and improve patient care.Currently,CIAM is not recognized as a subtype of mixed neuroendocrine-nonneuroendocrine neoplasm by WHO.
